Leading global law firm Herbert Smith Freehills Kramer has advised Morgan Stanley Asia Limited and CITIC Securities (Hong Kong) Limited as joint sponsors and the underwriters of Medtide Inc. (03880.HK)'s H share listing on the Main Board of the Hong Kong Stock Exchange.

"This listing reflects renewed momentum in Hong Kong’s healthcare IPO market, with investor appetite returning," said Hong Kong partner Matt Emsley. "As a global capital hub and China’s innovation gateway, Hong Kong remains the destination of choice for healthcare companies seeking international exposure."

Medtide is a peptide-focused CRDMO (Contract Research, Development, and Manufacturing Organisation), offering full-cycle services ranging from early-stage discovery, preclinical research and clinical development to commercial-stage production. According to Frost & Sullivan, Medtide is the third largest peptide-focused CRDMO worldwide in terms of sales revenue in 2023.

Medtide listed on the Hong Kong Stock Exchange on 30 June 2025. This is the second healthcare IPO on which the firm has advised in a month.

"We congratulate Medtide on its successful listing on the Hong Kong Stock Exchange," said Beijing partner Stanley Xie. "Our track record in healthcare IPOs speaks to the depth of our sector expertise and commitment to clients' success."

Herbert Smith Freehills Kramer is a leading Hong Kong IPO adviser for healthcare companies. In the past five years, the firm has advised on 26 healthcare company listings on the Hong Kong Stock Exchange, including Jiangsu Hengrui Pharmaceuticals (01276.HK), QuantumPharm Inc. (02228.HK), Lepu ScienTech Medical (02291.HK), Biocytogen Pharmaceuticals (02315.HK), CARsgen Therapeutics (02171.HK), Abbisko (02256.HK), Simcere (02096.HK), among others.

Partners Matt Emsley, Stanley Xie and Jin Kong* jointly led a cross-office team advising the underwriters, assisted by Jaime Fong, Sean Ji, Crystal Chan, Reagan Li and Wang Ting. Primrose Ho, Betty Zhou, Susan Zou and Emily Wan also provided assistance.

Legal manager Marine Jin led Herbert Smith Freehills Kewei Joint Operation’s Digital Legal Delivery business to provide high-efficiency solutions for verification and other document-intensive processes during the listing, assisted by legal specialist Jean Zhou, senior legal analyst Chloe Hu and legal analyst Chunqin Li.

*According to regulatory requirements, Jin Kong's official title is Senior Registered Foreign Lawyer in Hong Kong.

Key contacts

Stanley Xie photo

Stanley Xie

Chief Representative, Head of Beijing, Mainland China and Beijing

Jin Kong photo

Jin Kong

Senior Registered Foreign Lawyer (New York, USA), Hong Kong


Media contact

For further information on this news article, please contact:

Sally Greig

Head of Communications, Asia

Hong Kong

Vivian Huang

Communications Manager, China

Beijing

Stay in the know

We’ll send you the latest insights and briefings tailored to your needs

Subscribe now
Mainland China Hong Kong Capital markets Equity capital markets Corporate Pharmaceuticals and healthcare Matthew Emsley Stanley Xie Jin Kong